Cyclophosphamide induced CD11b+ cells can inhibit anti-CD40 monoclonal antibody (mAb) therapy of B-cell lymphoma

被引：0
|
作者：
Honeychurch, J [1 ]
Glennie, MJ [1 ]
Johnson, PW [1 ]
Illidge, TM [1 ]
机构：
[1] Univ Southampton, Canc Sci Div, Southampton, Hants, England
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.3280.3280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3280
引用
收藏
页码：896A / 896A
页数：1
相关论文
共 50 条
  • [1] Cyclophosphamide induced CD11B+ cells can inhibit anti-CD40 monoclonal antibody therapy of B-cell lymphoma
    Honeychurch, J
    Glennie, MJ
    Illidge, TM
    BRITISH JOURNAL OF CANCER, 2004, 91 : S64 - S64
  • [2] Cyclophosphamide inhibition of anti-CD40 monoclonal antibody-based therapy of B cell lymphoma is dependent on CD11b+ cells
    Honeychurch, J
    Glennie, LJ
    Illidge, TM
    CANCER RESEARCH, 2005, 65 (16) : 7493 - 7501
  • [3] Macrophage depletion can enhance combined radiation and anti-CD40 monoclonal antibody therapy of B-Cell lymphoma.
    Honeychurch, Jamie
    Illidge, Tim M.
    BLOOD, 2006, 108 (11) : 708A - 709A
  • [4] Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma
    Honeychurch, J
    Glennie, MJ
    Johnson, PWM
    Illidge, TM
    BLOOD, 2003, 102 (04) : 1449 - 1457
  • [5] Monoclonal antibody therapy for B-Cell lymphoma: Clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan
    Tobinai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 411 - 419
  • [6] Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan
    Kensei Tobinai
    International Journal of Hematology, 2002, 76 : 411 - 419
  • [7] T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibody
    Tutt, AL
    O'Brien, L
    Hussain, A
    Crowther, GR
    French, RR
    Glennie, MJ
    JOURNAL OF IMMUNOLOGY, 2002, 168 (06): : 2720 - 2728
  • [8] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [9] T-cell infiltrate after monoclonal anti-CD20 antibody therapy for B-cell lymphoma
    Vincent-Salomon, A
    Mathiot, C
    MacIntyre, E
    Girre, V
    Fourquet, A
    Mercier, C
    Fréneaux, P
    Dumont, J
    Decaudin, D
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 387 - +
  • [10] CD20-negative relapse of cutaneous B-cell lymphoma after anti-CD20 monoclonal antibody therapy
    Massengale, WT
    McBurney, E
    Gurtler, J
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (03) : 441 - 443
12345